Got my friend out of NAL at just under $2, we understand the stock. That's what counts.
Anyway, when is NAL's US patent coming thru for their tech, and how secure is a patent on a procedure. Whats stopping a US company from coming along, changing the drug slightly and doing the same thing?
The market cap of NAL is just what people decide what its worth at the time, and it was clear from the high volume on near the top and directors selling that it was in distribution phase up there..
I'm not keen to enter yet, needs more consolidation..
NAL Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
